Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Glutamate receptor ionotropic, AMPA | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | ATP-binding cassette transporter | 0.003 | 0.026 | 0.0229 |
Schistosoma mansoni | adenosine deaminase-related | 0.0089 | 1 | 1 |
Echinococcus granulosus | glutamate receptor 2 | 0.0036 | 0.1217 | 0.1189 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0036 | 0.1217 | 0.1189 |
Echinococcus granulosus | adenosine deaminase | 0.0089 | 1 | 1 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.0089 | 1 | 1 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.004 | 0.1867 | 0.1841 |
Echinococcus granulosus | nmda type glutamate receptor | 0.004 | 0.1867 | 0.1841 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Trypanosoma brucei | AMP deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Trypanosoma cruzi | adenosine monophosphate deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Schistosoma mansoni | glutamate receptor AMPA | 0.003 | 0.026 | 0.0229 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0036 | 0.1217 | 0.1189 |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | 0.003 | 0.026 | 0.0229 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.5184 | 0.5169 |
Leishmania major | adenine aminohydrolase | 0.0089 | 1 | 1 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.0089 | 1 | 1 |
Chlamydia trachomatis | glutamine binding protein | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Echinococcus multilocularis | glutamate receptor 2 | 0.003 | 0.026 | 0.0229 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0089 | 1 | 1 |
Schistosoma mansoni | adenosine deaminase | 0.0089 | 1 | 1 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.004 | 0.1867 | 0.1841 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.5184 | 0.5169 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0089 | 1 | 0.5 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0036 | 0.1217 | 0.1189 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0089 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.5184 | 0.5169 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0089 | 1 | 0.5 |
Echinococcus multilocularis | adenosine deaminase | 0.0089 | 1 | 1 |
Trypanosoma brucei | AMP deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Schistosoma mansoni | glutamate receptor AMPA | 0.003 | 0.026 | 0.0229 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0089 | 1 | 1 |
Echinococcus granulosus | glutamate NMDA receptor subunit | 0.003 | 0.026 | 0.0229 |
Schistosoma mansoni | glutamate receptor NMDA | 0.003 | 0.026 | 0.0229 |
Mycobacterium ulcerans | adenosine deaminase | 0.0089 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 1 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0036 | 0.1217 | 0.1189 |
Loa Loa (eye worm) | glutamate receptor 2 | 0.003 | 0.026 | 0.0229 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0036 | 0.1217 | 0.1189 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.5184 | 0.5169 |
Trypanosoma brucei | adenosine monophosphate deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Brugia malayi | Glutamate receptor 2 precursor | 0.003 | 0.026 | 0.0229 |
Loa Loa (eye worm) | glutamate receptor 1 | 0.003 | 0.026 | 0.0229 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0036 | 0.1217 | 0.1189 |
Plasmodium falciparum | adenosine deaminase | 0.0089 | 1 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0036 | 0.1217 | 0.1189 |
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.0029 | 0 | 0.5 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.0089 | 1 | 0.5 |
Trypanosoma brucei | AMP deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Schistosoma mansoni | glutamate receptor kainate | 0.003 | 0.026 | 0.0229 |
Trypanosoma cruzi | AMP deaminase 2, putative | 0.0029 | 0.0031 | 0.5 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0036 | 0.1217 | 0.1189 |
Schistosoma mansoni | glutamate receptor kainate | 0.003 | 0.026 | 0.0229 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0036 | 0.1217 | 0.1189 |
Schistosoma mansoni | glutamate receptor kainate | 0.003 | 0.026 | 0.0229 |
Treponema pallidum | adenosine deaminase | 0.0089 | 1 | 1 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0089 | 1 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0036 | 0.1217 | 0.1189 |
Plasmodium vivax | adenosine deaminase, putative | 0.0089 | 1 | 1 |
Brugia malayi | Glutamate receptor 1 precursor | 0.003 | 0.026 | 0.0229 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0029 | 0.0031 | 0.5 |
Trypanosoma cruzi | adenosine monophosphate deaminase-like protein, putative | 0.0029 | 0.0031 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 1000 nM | Ability to block kainate-induced 45 [Ca2+] influx through functional assay of Ionotropic glutamate receptor AMPA activity in rat cerebellar granule cells | ChEMBL. | 11206453 |
IC50 (functional) | > 1000 nM | Ability to block kainate-induced 45 [Ca2+] influx through functional assay of Ionotropic glutamate receptor AMPA activity in rat cerebellar granule cells | ChEMBL. | 11206453 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.